The 42nd annual Miami Breast Cancer Conference was held from March 6-9, 2025. Visit the links below to explore some of the topics covered at this meeting for people with MBC.
- Cure Today: A clinical social worker talks about strategies for having difficult conversations in breast cancer care
- OncLive: Treatments received by mouth or by IV may be preferred over surgery or radiation for HER2-positive MBC that has spread to the brain
- OncLive: Dr. Hope Rugo reviewed several oral medications that are being investigated for use when a person with MBC develops resistance to hormone therapy and a CDK4/6 inhibitor
- OncLive: The experimental CDK4 inhibitor, atirmociclib and the aromatase inhibitor, letrozole (Femara®) showed promising safety and efficacy in hormone receptor-positive, HER2-negative MBC